NCT03404635

Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism

Monotherapy Anticoagulation To Expedite Home Treatment of Venous

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,300 (actual)
• Sponsor: Indiana University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Prospective, multicenter observational study, of the effectiveness of a standard of care protocol implemented to enhance home treatment of VTE. Study population will be selected as part of usual care as eligible for home treatment. Study personnel will travel to participating institutions to qualify the sites, deliver a Powerpoint® lecture to introduce the protocol, meet and train site principal investigators, emergency physicians and research personnel on the implementation of the protocol as part of usual clinical care, and data collection methods for a quality assurance registry with plans to use the data collected in this registry in future publications. Follow-up will be 30 days using medical records and/or telephone interview to assess for primary outcomes of bleeding or VTE recurrence.

Conditions

• Venous Thromboembolism

Interventions

Type	Name	Description
DRUG	Apixaban	Apixaban as standard of care for VTE
DRUG	Rivaroxaban	Rivaroxaban as standard of care for VTE

Timeline

• Start date: 2017-08-04
• Primary completion: 2020-05-08
• Completion: 2020-05-08
• First posted: 2018-01-19
• Last updated: 2020-08-07

Locations

2 sites across 1 country: United States